DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Cavalli G, De Luca G, Campochiaro C. et al.
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Lancet Rheumatol 2020;
2: e325-e331
DOI: 10.1016/s2665-9913(20)30127-2.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.